SCHEMBL7287094

SCHEMBL7287094

Cc1ncoc1CN1CCc2c(c3cccc(F)c3n2C)C1=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.46
KCNH2 Q12809 4/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADRA2C P18825 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR3A P46098 1/20 0.46
CASP6 P55212 1/20 0.46
HRH3 Q9Y5N1 2/20 0.33
PARG Q86W56 1/20 0.33
JAK2 O60674 2/20 0.32
BTK Q06187 2/20 0.32
HTR1A P08908 4/20 0.32
DRD2 P14416 4/20 0.32
P2RX7 Q99572 2/20 0.31
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979 0.85 HTR2A (0.63) HTR2AKCNH2HTR2CHTR2BCYP1A2
SCHEMBL7295411 0.79 HTR2A (0.49) HTR2AKCNH2HTR2CHTR2BCYP1A2
Lurosetron SCHEMBL788289 0.78 KCNH2 (0.72) HTR2AKCNH2HTR2CHTR2BCYP1A2
Lurosetron SCHEMBL30949356 0.78 KCNH2 (0.72) HTR2AKCNH2HTR2CHTR2BCYP1A2
Lurosetron SCHEMBL7336906 0.78 KCNH2 (0.71) HTR2AKCNH2HTR2CHTR2BCYP1A2
Lurosetron SCHEMBL7291773 0.78 CASP6 (0.72) HTR2AKCNH2HTR2CHTR2BCYP1A2
SCHEMBL7286207 0.77 KCNH2 (0.41) HTR2AKCNH2HTR2CHTR2BCYP1A2
Lurosetron SCHEMBL635328 0.75 KCNH2 (0.66) HTR2AKCNH2HTR2CHTR2BCYP1A2
SCHEMBL7285963 0.75 KCNH2 (0.45) HTR2AKCNH2HTR2CHTR2BCYP1A2
SCHEMBL9485728 0.74 KCNH2 (0.44) HTR2AKCNH2HTR2CHTR2BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed
EP-0353983-A2 Lactam derivatives GLAXO GROUP LIMITED (GB) 1990-02-07 EP disclosed